Marsha Rosner: CBD (Cannabidiol), Antiviral Drugs, SARS-CoV-2 & Cancer Biology | M&M #59
Mind & Matter
English - February 23, 2022 08:00 - 1 hour - 58.9 MB - ★★★★★ - 15 ratingsScience Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Nick Jikomes talks to cancer biologist Dr. Marsha Rosner, who is a Professor of Cancer Research at the University of Chicago. Her lab focuses largely on understanding the biochemical signaling mechanisms that lead to the generation of tumor cells, as well as how and why cancer cells metastasize, which is when they travel from one part of the body to another.
Nick and Dr. Rosner and discuss mainly a recent study she led about the antiviral effects of cannabidiol (CBD) against SARS-CoV-2, including: why a cancer lab was working with CBD to begin with; what the results of her study actually show in terms of CBD’s antiviral effects; whether other cannabinoids showed this effect. She also commented on some misconceptions that have been circulating regarding this work, and described some of the clinical trials her team is running to measure CBD’s potential as an anti-COVID drug.
SUPPORT M&M:
Sign up for the free weekly Mind & Matter newsletter:
[https://mindandmatter.substack.com/?sort=top]
Learn how you can further support the podcast:
[https://mindandmatter.substack.com/p/how-to-support-mind-and-matter]
Learn more about our podcast sponsor, Dosist
[https://dosist.com]
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.